G-Protein Coupled Receptors Market Report 2026

G-Protein Coupled Receptors Market Overview

• G-Protein Coupled Receptors market size has reached to $3.4 billion in 2025 • Expected to grow to $4.77 billion in 2030 at a compound annual growth rate (CAGR) of 7% • Growth Driver: G-Protein-Coupled Receptors Market Poised For Growth Driven By Escalating Cancer Prevalence • Market Trend: Major Companies In The G-Protein Coupled Receptors Market Drive Innovation Through IPOs To Fund Drug Development Targeting Chronic Diseases • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under G-Protein Coupled Receptors Market?

G-protein coupled receptors refer to a kind of membrane receptor also known as seven-(pass)-transmembrane receptors. These are present in the cell membrane and are in charge of binding extracellular chemicals and sending signals from these substances to an intracellular molecule. GPCRs are the largest family of membrane proteins and mediate most cellular responses to hormones and neurotransmitters, and being responsible for vision, olfaction, and taste. The main products of G-protein-coupled receptors are cell lines, detection kits, cell culture reagents, and ligands. A cell line is a cell culture that has been chosen for uniformity from a population of cells taken from a typically homogeneous tissue source. The multiple types of assays are included, such as camp functional assays, calcium functional assays, β-arrestin functional assays, radioligand binding and GTPγS functional assays, internalization assays, and trafficking assays, which are used in various applications, including cancer research, CNS research, metabolic research, cardiovascular research, inflammation research, respiratory research, and others.

What Is The G-Protein Coupled Receptors Market Growth Forecast?

The g-protein coupled receptors market size is expected to see strong growth in the next few years. It will grow to $4.77 billion in 2030 at a compound annual growth rate (CAGR) of 7.0%. The growth in the forecast period can be attributed to precision drug targeting demand, AI-driven drug discovery, biologics pipeline growth, receptor deorphanization research, investment in translational research. Major trends in the forecast period include rising use of GPCR targets in drug discovery, expansion of high-throughput screening, increased focus on orphan receptor research, growth of cell-based assay technologies, increased academic and pharmaceutical collaboration.

Global G-Protein Coupled Receptors Market Segmentation

1) By Product: Cell Lines, Detection Kits, Cell Culture Reagents, Ligands 2) By Assay: CAMP Functional Assays, Calcium Functional Assays, β-Arrestin Functional Assays, Radioligand Binding And GTPγS Functional Assays, Internalization Assays, Trafficking Assays 3) By Applications: Cancer Research, CNS Research, Metabolic Research, Cardiovascular Research, Inflammation Research, Respiratory Research, Other Applications Subsegments: 1) By Cell Lines: GPCR-Expressing Cell Lines, Stable And Transient Cell Lines 2) By Detection Kits: ELISA Kits, High-Throughput Screening Kits, Reporter Gene Assays 3) By Cell Culture Reagents: Media And Supplements, Transfection Reagents, Growth Factors 4) By Ligands: Agonists, Antagonists, Inverse Agonists

What Is The Driver Of The G-Protein Coupled Receptors Market?

The rising prevalence of cancer is expected to propel the growth of the G-protein-coupled receptors market going forward. Cancer is an illness in which abnormal cells can infect surrounding tissues and spread uncontrollably. The lymphatic and vascular systems of the body are further routes by which cancer cells might spread. GPCRs control the processes identified as the defining characteristics of cancer, including proliferative signaling, replicative immortality, evasion of growth suppressors, resistance to apoptosis, and the activation of invasion and metastasis. For instance, in January 2023, the American Cancer Society, a US-based professional organizations company reported that 1,958,310 new cancer cases were diagnosed in the United States in 2023, an increase from the estimated 1.9 million new cases in 2022. Therefore, the rising prevalence of cancer is driving the growth of the G-protein coupled receptors industry.

Key Players In The Global G-Protein Coupled Receptors Market

Major companies operating in the g-protein coupled receptors market are Pfizer Inc., Roche Holding AG, AbbVie Inc., Bayer AG, Novartis International AG, Sanofi SA, Bristol-Myers Squibb Company, AstraZeneca Plc, GlaxoSmithKline Plc, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Merck KGaA, Boehringer Ingelheim, Daiichi Sankyo Company Limited, Danaher Corporation, Thermo Fisher Scientific Inc., PerkinElmer Inc., Bio-Techne Corporation, Abcam PLC, Cara Therapeutics Inc., Sosei Heptares Ltd., Eurofins DiscoverX Corporation, Crinetics Pharmaceuticals Inc., Domain Therapeutics SA, Addex Pharmaceuticals Ltd., Structure Therapeutics, Septerna

Global G-Protein Coupled Receptors Market Trends and Insights

Major companies operating in the G-protein coupled receptors market are raising Initial Public Offering (IPO) focused on developing drugs targeting G protein-coupled receptors (GPCRs) to accelerate research and development, advance clinical trials, and bring innovative therapies to market for a range of diseases, including cancer, neurological disorders, and metabolic conditions. The funds raised will primarily support the development of the company's lead product candidates targeting chronic metabolic and pulmonary diseases. Specifically, the proceeds are earmarked for advancing their glucagon-like peptide-1 receptor (GLP-1R) agonist program, which focuses on treatments for diabetes and obesity. For instance, in February 2023, Structure Therapeutics Inc, a US-based company, completed its initial public offering (IPO), raising $161 million to advance its development of G-protein coupled receptor (GPCR)-based therapeutics. The company offered 10,740,000 American depositary shares (ADSs) for $15.00 per ADS, representing a significant increase from its initial projections. The shares began trading on the Nasdaq Global Market under the ticker symbol 'GPCR'.

What Are Latest Mergers And Acquisitions In The G-Protein Coupled Receptors Market?

In December 2023, Danaher Corporation a US-based company, acquired Abcam Plc for an undisclosed amount. With this acquisition, Danaher aims to expand its portfolio by incorporating Abcam's expertise in providing G-protein coupled receptors (GPCR). Abcam Plc is a UK-based company that offers G-protein coupled receptors (GPCR).

Regional Outlook

North America was the largest region in the G-protein coupled receptors market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the G-Protein Coupled Receptors Market?

The G-protein-coupled receptors market consists of revenues earned by entities by providing GPCR screening and profiling services, GPCR antibodies and immunoassays, hormones visual control. The market value includes the value of related goods sold by the service provider or included within the service offering. The G-protein-coupled receptors market also includes sales of adenosine, serotonin, and metabotropic receptor. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the G-Protein Coupled Receptors Market Report 2026?

The g-protein coupled receptors market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the g-protein coupled receptors industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.